摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[4-(己氧基)苯基]甲胺 | 4950-91-8

中文名称
1-[4-(己氧基)苯基]甲胺
中文别名
——
英文名称
[4-(hexyloxy)phenyl]methanamine
英文别名
4-hexyloxybenzylamine;(4-hexoxyphenyl)methanamine
1-[4-(己氧基)苯基]甲胺化学式
CAS
4950-91-8
化学式
C13H21NO
mdl
——
分子量
207.316
InChiKey
ACNSGHYWIIECBM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    315.9±17.0 °C(Predicted)
  • 密度:
    0.959±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    15
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    35.2
  • 氢给体数:
    1
  • 氢受体数:
    2

SDS

SDS:b357a88f130addf429308e267a37261f
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Lipophilicity-related inhibition of blood platelet aggregation by nipecotic acid anilides
    摘要:
    Using N-[4-(hexyloxy)phenyl]piperidine-3-carboxamide (17c) as a structural lead, a number of isomers, derivatives, and ring-opened analogs were synthesized and tested for their ability to block the in vitro aggregation of human platelets induced by adenosine 5'-diphosphate (ADP). For the most active compounds, inhibition of the platelet aggregation triggered by arachidonic acid (AA) and ADP-induced intraplatelet calcium mobilization was also demonstrated. Based on quantitative structure-activity relationships (QSARs), we proved the impact of hydrophobicity on antiplatelet activity by a nonlinear (parabolic or bilinear) relationship between pIC(50) and lipophilicity, as assessed by RP-HPLC capacity factors and Clog P (i.e. calculated 1-octanol-water partition coefficients). This study highlighted the following additional SARs: quasi-isolipophilic isomers of 17c (isonipecotanilides and pipecolinanilides) and ring-opened analogs (e.g. anilide of beta-alanine) exhibited lower antiplatelet activity; methylation of the piperidine nitrogen of 17c has no effect, whereas alkylation with an n-propyl group decreases the activity by a factor of approximately 2, most likely due to a conformation-dependent decrease in lipophilicity. (C) 2004 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.ejps.2004.03.003
  • 作为产物:
    描述:
    对(己氧基)苄腈甲烷 氢气 作用下, 以 乙醇 为溶剂, 反应 2.0h, 以67%的产率得到1-[4-(己氧基)苯基]甲胺
    参考文献:
    名称:
    Lipophilicity-related inhibition of blood platelet aggregation by nipecotic acid anilides
    摘要:
    Using N-[4-(hexyloxy)phenyl]piperidine-3-carboxamide (17c) as a structural lead, a number of isomers, derivatives, and ring-opened analogs were synthesized and tested for their ability to block the in vitro aggregation of human platelets induced by adenosine 5'-diphosphate (ADP). For the most active compounds, inhibition of the platelet aggregation triggered by arachidonic acid (AA) and ADP-induced intraplatelet calcium mobilization was also demonstrated. Based on quantitative structure-activity relationships (QSARs), we proved the impact of hydrophobicity on antiplatelet activity by a nonlinear (parabolic or bilinear) relationship between pIC(50) and lipophilicity, as assessed by RP-HPLC capacity factors and Clog P (i.e. calculated 1-octanol-water partition coefficients). This study highlighted the following additional SARs: quasi-isolipophilic isomers of 17c (isonipecotanilides and pipecolinanilides) and ring-opened analogs (e.g. anilide of beta-alanine) exhibited lower antiplatelet activity; methylation of the piperidine nitrogen of 17c has no effect, whereas alkylation with an n-propyl group decreases the activity by a factor of approximately 2, most likely due to a conformation-dependent decrease in lipophilicity. (C) 2004 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.ejps.2004.03.003
点击查看最新优质反应信息

文献信息

  • Ionic metallomesogens derived from silver(I) bis-amine complexes: Structure and mesogenic behavior
    作者:María del Carmen Lequerica、María Jesús Baena、Pablo Espinet
    DOI:10.1016/j.ica.2007.11.033
    日期:2008.6
    Abstract Complexes [Ag(NH 2 R) 2 ]X, (X = NO 3 , R = –C 6 H 4 –C n H 2 n +1 - p , –C 6 H 4 –O–C n H 2 n +1 - p , –CH 2 –C 6 H 4 –O–C n H 2 n +1 - p , n = 6, 8, 10, 12, 14; X = BF 4 , R = –CH 2 –C 6 H 4 –O–C n H 2 n +1 - p , n = 6, 8, 10, 12, 14; X = OAc, R = –CH 2 -C 6 H 4 –O–C 10 H 21 - p ; X = CF 3 SO 3 , R = –CH 2 –C 6 H 4 –O–C 10 H 21 - p ) have been prepared. They all show S A mesophases corresponding
    摘要[Ag(NH 2 R)2] X,(X = NO 3,R = –C 6 H 4 –C n H 2 n +1-p,–C 6 H 4 –O–C n H 2 n +1-p,–CH 2 –C 6 H 4 –OC–C n H 2 n +1-p,n = 6,8,10,12,14; X = BF 4,R = –CH 2 –C 6 H 4 -OC n H 2 n +1-p,n = 6、8、10、12、14; X = OAc,R = -CH 2 -C 6 H 4 -OC 10 H 21- p; X = CF 3 SO 3,R = -CH 2 -C 6 H 4 -OC-C 10 H 21 -p)。它们都显示出与固态已经存在的两种结构相对应的SA中间相。烷基苯胺和烷氧基苯胺衍生物采用双层结构,其中阳离子具有扩展的中心对称构象。苄胺衍生物含有U型阳离子,形成一个双层结构,该结构允许分子的有机部分与无机Ag +(阴离子)部分发生微分离。
  • AMINE COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC, AND ANTICANCER ACTIVITY
    申请人:WELLSTAT THERAPEUTICS CORPORATION
    公开号:US20150361077A1
    公开(公告)日:2015-12-17
    Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.
    本文描述了对炎症、真菌、单细胞寄生微生物和癌症具有活性的胺化合物。这些化合物包含一个单环、双环或三环芳香环,其中含有一个、两个或三个环氮原子。
  • Amine compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity
    申请人:Wellstat Therapeutics Corporation
    公开号:US10030015B2
    公开(公告)日:2018-07-24
    Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.
    本文描述了具有抗炎、抗真菌、抗单细胞寄生微生物和抗癌活性的胺化合物。这些化合物含有单环、双环或三环芳香环,环上有一个、两个或三个氮原子。
  • Aminoquinazoline compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity
    申请人:Wellstat Therapeutics Corporation
    公开号:US10934284B2
    公开(公告)日:2021-03-02
    Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.
    本文描述了具有抗炎、抗真菌、抗单细胞寄生微生物和抗癌活性的胺化合物。这些化合物含有单环、双环或三环芳香环,环上有一个、两个或三个氮原子。
  • Antiprotozoal quinones. II. Synthesis of 4-amino-1,2-naphthoquinones and related compounds as potential antimalarials
    作者:F. J. Bullock、J. F. Tweedie、D. D. McRitchie、M. A. Tucker
    DOI:10.1021/jm00295a025
    日期:1970.1
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐